ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.

CongXiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.